Resmed (RSMDF) FCF Margin (2009 - 2026)
Resmed's (RSMDF) quarterly FCF Margin came in at 27.57% in Q2 2026, down 1013.0% on a YoY basis from 3.02% in Q2 2025, and down 24.18% quarter-over-quarter from 36.36% in Q1 2026.
Powered by 
Analysis
Resmed (RSMDF) FCF Margin (2009 - 2026) Analysis & Trends
Resmed (RSMDF) has reported FCF Margin for 18 consecutive years, with 27.57% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin fell 1013.0% year-over-year to 27.57%; the trailing twelve-month figure through Jun 2026 stood at 29.18% (down 311.0% YoY), and the FY2026 full-year result was 29.18%, down 311.0% from the prior year.
- FCF Margin eased to 27.57% in Q2 2026 per RSMDF's latest filing, from 36.36% in the prior quarter.
- Across five years, FCF Margin topped out at 43.19% in Q1 2025 and bottomed at 1.64% in Q3 2022.
- Historically, FCF Margin has averaged 23.42% across 5 years, with a median of 22.98% in 2023.
- The sharpest annual moves came in 2022 and 2023: FCF Margin tumbled 1711 bps in 2022, then surged 2160 bps in 2023.
- Over 5 years, FCF Margin stood at 9.8% in 2022, then jumped by 119 bps to 21.46% in 2023, then gained by 5 bps to 22.46% in 2024, then declined by 3 bps to 21.87% in 2025, then gained by 26 bps to 27.57% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 27.57%, 36.36%, and 21.87% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.06 Bn | 178.46 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 118.26 Bn | 109.44 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 104.56 Bn | 101.08 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.62 Bn | 45.37 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 21.14 Bn | 20.65 Bn | 684.20 Mn | 18.73% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 27.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.57% |
| Mar 31, 2026 | 36.36% |
| Dec 31, 2025 | 21.87% |
| Sep 30, 2025 | 31.02% |
| Jun 30, 2025 | 37.70% |
| Mar 31, 2025 | 43.19% |
| Dec 31, 2024 | 22.46% |
| Sep 30, 2024 | 25.13% |
| Jun 30, 2024 | 33.95% |
| Mar 31, 2024 | 31.82% |
| Dec 31, 2023 | 21.46% |
| Sep 30, 2023 | 23.25% |
| Jun 30, 2023 | 18.09% |
| Mar 31, 2023 | 22.72% |
| Dec 31, 2022 | 9.80% |
| Sep 30, 2022 | 1.64% |
| Jun 30, 2022 | 5.56% |
| Mar 31, 2022 | 7.98% |
| Dec 31, 2021 | 21.17% |
| Sep 30, 2021 | -10.29% |